Advertisement

Oncology

Biotechnology company RadioMedix has raised $40 million in series A funding; the company plans to use the new funding to advance its flagship radiopharmaceutical, AlphaMedix.

Advertisement

Here are five oncology firsts Becker's has covered since Sept. 12:

Advertisement